REPORTS

Let’s Pullulate and Expand Your Business

Antibody Drug Conjugates Market - Global Professional Analysis and Forecast to 2026

Mar 28, 2020  |  170 PAGES  |  REPORT CODE: CMM274223
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Antibody Drug Conjugates market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.8% during the forecast period.

This report presents the market size and development trends by detailing the Antibody Drug Conjugates market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Antibody Drug Conjugates market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Antibody Drug Conjugates industry and will help you to build a panoramic view of the industrial development.

Antibody Drug Conjugates Market, By Type:

  • Adcetris

  • Kadcyla

Antibody Drug Conjugates Market, By Application:

  • Breast Cancer

  • Lymphoma

Some of the leading players are as follows:

  • Genentech

  • F. Hoffman-La Roche

  • Progenics Pharmaceuticals

  • Bayer Healthcare Pharmaceuticals

  • Seattle Genetics

  • Immunogen

  • Takeda Pharmaceutical

  • Novartis AG

  • Pfizer

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Antibody Drug Conjugates Market: Technology Type Analysis

  • 4.1 Antibody Drug Conjugates Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Antibody Drug Conjugates Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Adcetris

    • 4.3.2 Kadcyla

5 Antibody Drug Conjugates Market: Product Analysis

  • 5.1 Antibody Drug Conjugates Product Market Share Analysis, 2018 & 2026

  • 5.2 Antibody Drug Conjugates Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Antibody Drug Conjugates Market: Application Analysis

  • 6.1 Antibody Drug Conjugates Application Market Share Analysis, 2018 & 2026

  • 6.2 Antibody Drug Conjugates Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Breast Cancer

    • 6.3.2 Lymphoma

7 Antibody Drug Conjugates Market: Regional Analysis

  • 7.1 Antibody Drug Conjugates Regional Market Share Analysis, 2018 & 2026

  • 7.2 Antibody Drug Conjugates Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Genentech

    • 9.1.1 Genentech Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 F. Hoffman-La Roche

    • 9.2.1 F. Hoffman-La Roche Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Progenics Pharmaceuticals

    • 9.3.1 Progenics Pharmaceuticals Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Bayer Healthcare Pharmaceuticals

    • 9.4.1 Bayer Healthcare Pharmaceuticals Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Seattle Genetics

    • 9.5.1 Seattle Genetics Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Immunogen

    • 9.6.1 Immunogen Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Takeda Pharmaceutical

    • 9.7.1 Takeda Pharmaceutical Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Novartis AG

    • 9.8.1 Novartis AG Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Pfizer

    • 9.9.1 Pfizer Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

 

The List of Tables and Figures (Totals 61 Figures and 133 Tables)

  • Figure Adcetris Antibody Drug Conjugates market, 2015 - 2026 (USD Million)

  • Figure Kadcyla Antibody Drug Conjugates market, 2015 - 2026 (USD Million)

  • Figure Breast Cancer market, 2015 - 2026 (USD Million)

  • Figure Lymphoma market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Antibody Drug Conjugates market, by country, 2015 - 2026 (USD Million)

  • Table North America Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table North America Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table North America Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Canada Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Canada Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Europe Antibody Drug Conjugates market, by country, 2015 - 2026 (USD Million)

  • Table Europe Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Europe Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Europe Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Germany Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Germany Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table France Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table France Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Italy Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Italy Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Spain Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Spain Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antibody Drug Conjugates market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table China Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table China Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Japan Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Japan Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table India Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table India Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Antibody Drug Conjugates market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table MEA Antibody Drug Conjugates market, by country, 2015 - 2026 (USD Million)

  • Table MEA Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table MEA Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table MEA Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Antibody Drug Conjugates market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Antibody Drug Conjugates market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Antibody Drug Conjugates market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Genentech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table F. Hoffman-La Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Progenics Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Healthcare Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Seattle Genetics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Immunogen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Takeda Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top